scholarly article | Q13442814 |
P50 | author | Paolo Gresele | Q37834337 |
Loredana Bury | Q47504113 | ||
Andrew Weyrich | Q72089065 | ||
P2093 | author name string | Neal D Tolley | |
Luca Cecchetti | |||
Noemi Michetti | |||
P2860 | cites work | The composition of Staufen-containing RNA granules from human cells indicates their role in the regulated transport and translation of messenger RNAs | Q24338478 |
Platelet genomics and proteomics in human health and disease | Q24536151 | ||
Identification, regulation and role of tissue inhibitor of metalloproteinases-4 (TIMP-4) in human platelets | Q24672897 | ||
Signal-dependent translation of a regulatory protein, Bcl-3, in activated human platelets | Q24675173 | ||
Barentsz, a new component of the Staufen-containing ribonucleoprotein particles in mammalian cells, interacts with Staufen in an RNA-dependent manner | Q28185024 | ||
Platelets release active matrix metalloproteinase-2 in vivo in humans at a site of vascular injury: lack of inhibition by aspirin | Q28217638 | ||
Platelet expression profiling and clinical validation of myeloid-related protein-14 as a novel determinant of cardiovascular events | Q28238975 | ||
The EJC factor eIF4AIII modulates synaptic strength and neuronal protein expression | Q28567381 | ||
Single mRNA molecules demonstrate probabilistic movement in living mammalian cells | Q30716659 | ||
Analysis of SAGE data in human platelets: features of the transcriptome in an anucleate cell | Q31036312 | ||
The biogenesis of platelets from megakaryocyte proplatelets | Q33369405 | ||
The platelet interior revisited: electron tomography reveals tubular alpha-granule subtypes | Q33571290 | ||
Membrane-type matrix metalloproteinases | Q33586502 | ||
Pervasive regulation of Drosophila Notch target genes by GY-box-, Brd-box-, and K-box-class microRNAs | Q33780723 | ||
Existence of a microRNA pathway in anucleate platelets | Q34025954 | ||
Megakaryocytes and beyond: the birth of platelets | Q34215516 | ||
Selective sorting of alpha-granule proteins | Q34415721 | ||
Escaping the nuclear confines: signal-dependent pre-mRNA splicing in anucleate platelets | Q34442383 | ||
mRNA localization: gene expression in the spatial dimension | Q34951203 | ||
Expression of matrix metalloproteinase-9 in human platelets: regulation of platelet activation in in vitro and in vivo studies | Q35047618 | ||
mTOR-dependent synthesis of Bcl-3 controls the retraction of fibrin clots by activated human platelets. | Q35642870 | ||
Change in protein phenotype without a nucleus: translational control in platelets | Q35881295 | ||
Signal-dependent splicing of tissue factor pre-mRNA modulates the thrombogenicity of human platelets. | Q36228070 | ||
Blood platelets are assembled principally at the ends of proplatelet processes produced by differentiated megakaryocytes | Q36313419 | ||
Amplified expression profiling of platelet transcriptome reveals changes in arginine metabolic pathways in patients with sickle cell disease | Q36428347 | ||
Mechanics of proplatelet elaboration | Q36884299 | ||
Signal-dependent protein synthesis by activated platelets: new pathways to altered phenotype and function. | Q36996283 | ||
Potentiation and priming of platelet activation: a potential target for antiplatelet therapy | Q37186204 | ||
PAF-acetylhydrolase expressed during megakaryocyte differentiation inactivates PAF-like lipids. | Q37262394 | ||
Activated platelets signal chemokine synthesis by human monocytes | Q37353355 | ||
Loss of matrix metalloproteinase 2 in platelets reduces arterial thrombosis in vivo. | Q37402384 | ||
Notch signaling specifies megakaryocyte development from hematopoietic stem cells. | Q37673550 | ||
De novo protein synthesis in mature platelets: a consideration for transfusion medicine | Q37719648 | ||
Integrins regulate the intracellular distribution of eukaryotic initiation factor 4E in platelets. A checkpoint for translational control. | Q38299411 | ||
Transcript profiling of human platelets using microarray and serial analysis of gene expression | Q38360981 | ||
Integration of proteomics and genomics in platelets: a profile of platelet proteins and platelet-specific genes | Q38522436 | ||
Tissue inhibitors of matrix metalloproteinases in platelets and megakaryocytes: a novel organization for these secreted proteins. | Q39857738 | ||
Spatial regulation of beta-actin translation by Src-dependent phosphorylation of ZBP1. | Q40347909 | ||
Role of tissue inhibitor of metalloproteinases-2 (TIMP-2) in regulation of pro-gelatinase A activation catalyzed by membrane-type matrix metalloproteinase-1 (MT1-MMP) in human cancer cells | Q41020537 | ||
Platelet matrix metalloprotease-1 mediates thrombogenesis by activating PAR1 at a cryptic ligand site | Q42177034 | ||
Establishment of a novel human megakaryoblastic leukemia cell line, MEG-01, with positive Philadelphia chromosome | Q42819189 | ||
Suppression of 15-lipoxygenase synthesis by hnRNP E1 is dependent on repetitive nature of LOX mRNA 3'-UTR control element DICE. | Q43876606 | ||
Exogenous tissue inhibitor of metalloproteinase-1 promotes endothelial cell survival through activation of the phosphatidylinositol 3-kinase/Akt pathway | Q45230744 | ||
Intraplatelet signaling mechanisms of the priming effect of matrix metalloproteinase-2 on platelet aggregation | Q46767662 | ||
Ribosome association contributes to restricting mRNAs to the cell body of hippocampal neurons | Q48305610 | ||
Platelets release matrix metalloproteinase-2 in the coronary circulation of patients with acute coronary syndromes: possible role in sustained platelet activation. | Q53292318 | ||
Differential regulation of platelet aggregation by matrix metalloproteinases-9 and -2. | Q54067475 | ||
Platelet transcriptional profile and protein expression in patients with systemic lupus erythematosus: up-regulation of the type I interferon system is strongly associated with vascular disease. | Q54424737 | ||
Platelet release of trimolecular complex components MT1-MMP/TIMP2/MMP2: involvement in MMP2 activation and platelet aggregation. | Q54790635 | ||
Dynamic Visualization of Thrombopoiesis Within Bone Marrow | Q58450371 | ||
Release of gelatinase A during platelet activation mediates aggregation | Q59064159 | ||
Activation of the precursor of gelatinase A/72 kDa type IV collagenase/MMP-2 in lung carcinomas correlates with the expression of membrane-type matrix metalloproteinase (MT-MMP) and with lymph node metastasis | Q71820200 | ||
Outside-in signals delivered by matrix metalloproteinase-1 regulate platelet function | Q74211074 | ||
Differential regulation of matrix metalloproteinase-9 by monocytes adherent to collagen and platelets | Q74515086 | ||
Translation of glycoprotein IIIa in stored blood platelets | Q80832006 | ||
P433 | issue | 7 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | RNA sequencing | Q2542347 |
P304 | page(s) | 1903-1911 | |
P577 | publication date | 2011-05-31 | |
P1433 | published in | Blood | Q885070 |
P1476 | title | Megakaryocytes differentially sort mRNAs for matrix metalloproteinases and their inhibitors into platelets: a mechanism for regulating synthetic events | |
P478 | volume | 118 |
Q84630706 | Alteration of the platelet transcriptome in chronic kidney disease |
Q38262961 | Antithrombotic therapy: new areas to understand efficacy and bleeding |
Q98726775 | Blood platelet RNA enables the detection of multiple sclerosis |
Q48954046 | Blood platelets contain tumor-derived RNA biomarkers |
Q35676042 | Characterization of the cytokine profile of platelet rich plasma (PRP) and PRP-induced cell proliferation and migration: Upregulation of matrix metalloproteinase-1 and -9 in HaCaT cells |
Q36700678 | Circular RNA enrichment in platelets is a signature of transcriptome degradation |
Q54489626 | Differential MMP-9 activity in CD34⁺progenitor cell-derived foam cells from diabetic and normoglycemic patients. |
Q52147673 | Dynamic regulation of plasma matrix metalloproteinases in human diabetic ketoacidosis. |
Q45855083 | In vitro uptake of recombinant factor VIIa by megakaryocytes with subsequent production of platelets containing functionally active drug |
Q35128021 | Investigation of de novo unique differentially expressed genes related to evolution in exercise response during domestication in Thoroughbred race horses |
Q100944049 | Is there a relationship between morphological and functional platelet changes and depressive disorder? |
Q41099760 | MMP-2, MMP-9, and TIMP-4 and Response to Aspirin in Diabetic and Nondiabetic Patients with Stable Coronary Artery Disease: A Pilot Study. |
Q39005279 | Maternal plasma TIMP-4 levels combined with clinical risk factors for the early prediction of pregnancy-induced hypertension |
Q36542806 | Matrix metalloproteases and PAR1 activation |
Q58701086 | Megakaryocyte Contribution to Bone Marrow Fibrosis: many Arrows in the Quiver |
Q38543354 | MicroRNAs in platelet function and cardiovascular disease |
Q38117746 | MicroRNAs in platelet production and activation. |
Q47874989 | Molecular dynamics of FMRP and other RNA-binding proteins in MEG-01 differentiation: the role of mRNP complexes in non-neuronal development |
Q26821976 | NETosis: how vital is it? |
Q49922734 | Non-genomic effects of nuclear receptors: insights from the anucleate platelet. |
Q38768161 | Normalization of qPCR in platelets - YWHAE a potential genericreference gene |
Q39339846 | On the origin of matrix metalloproteinase-2 and -9 in blood platelets |
Q90434536 | Platelet Biogenesis in the Lung Circulation |
Q36004648 | Platelet Inhibitors Reduce Rupture in a Mouse Model of Established Abdominal Aortic Aneurysm |
Q39410921 | Platelet RNA as a circulating biomarker trove for cancer diagnostics |
Q36897250 | Platelet mRNA: the meaning behind the message |
Q43468988 | Platelet shedding of CD40L is regulated by matrix metalloproteinase-9 in abdominal sepsis |
Q26824744 | Platelet signaling |
Q36058568 | Platelets and platelet-like particles mediate intercellular RNA transfer |
Q50307674 | Platelets as a surrogate disease model of neurodevelopmental disorders: Insights from Fragile X Syndrome |
Q37081746 | Platelets as cellular effectors of inflammation in vascular diseases |
Q55004062 | Platelets in Immune Response to Virus and Immunopathology of Viral Infections. |
Q26739670 | Platelets in Pulmonary Immune Responses and Inflammatory Lung Diseases |
Q28244689 | Proteasome function is required for platelet production |
Q59281355 | Proteolytic processing of platelet receptors |
Q45130974 | Rac1 regulates platelet shedding of CD40L in abdominal sepsis |
Q38543301 | Regulation of the genetic code in megakaryocytes and platelets |
Q26860307 | Role of microparticles in dengue virus infection and its impact on medical intervention strategies |
Q33615612 | Slowed decay of mRNAs enhances platelet specific translation |
Q90419870 | Sub-Cellular Localization of Metalloproteinases in Megakaryocytes |
Q47725182 | Swarm Intelligence-Enhanced Detection of Non-Small-Cell Lung Cancer Using Tumor-Educated Platelets. |
Q30528922 | T granules in human platelets function in TLR9 organization and signaling |
Q52719266 | The Platelet Lifeline to Cancer: Challenges and Opportunities. |
Q58710868 | The endothelial glycocalyx anchors von Willebrand factor fibers to the vascular endothelium |
Q37607420 | The human platelet: strong transcriptome correlations among individuals associate weakly with the platelet proteome. |
Q38543312 | The role of circulating platelet transcripts |
Q40126127 | Thrombopoietin/TGF-β1 Loop Regulates Megakaryocyte Extracellular Matrix Component Synthesis. |
Q100995148 | Tumor-Educated Platelet RNA for the Detection and (Pseudo)progression Monitoring of Glioblastoma |
Q33575884 | Variance of matrix metalloproteinase (MMP) and tissue inhibitor of metalloproteinase (TIMP) concentrations in activated, concentrated platelets from healthy male donors |
Search more.